Aurobindo Pharma Ltd.

AUROPHARMA

₹1386.2

1.72% (23.4)

Market Cap

₹81,229 Cr.

P/E

25.60

About

Aurobindo Pharma Limited is a leading Active Pharmaceutical Ingredients (API) manufacturing company with a focus on cost leadership and flexibility. Its API business drives profitability and growth in… Read more

Aurobindo Pharma Limited is a leading Active Pharmaceutical Ingredients (API) manufacturing co… Read more

Low

806

52W Range

High

1410

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

7.18%

3yr Average

14.09%

5yr Average

15.24%

Net Profit Margin

Latest

7.75%

3yr Average

13.53%

5yr Average

13.0%

ROCE

Latest

9.97%

3yr Average

14.84%

5yr Average

18.44%

Debt to Equity

Latest

0.18

3yr Average

0.17

5yr Average

0.27

Market Share

6.80 %

(as of Mar 21)

Source/Historic

Rx Market Share - USA

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - API

Location Wise Break-Up

Dosage Form Break-Up - USA Formulation

Asset Break-Up

Operational Metrics

US DMF Filings (.)
Source
Europe DMF Filings (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Suppliers

Laurus Labs Ltd.
Atul Ltd.
Navin Fluorine International Ltd.
Neuland Laboratories Ltd.
Kirloskar Pneumatic Company Ltd.
Balaji Amines Ltd.
Shaily Engineering Plastics Ltd.
HLE Glascoat Ltd.
Chemcon Speciality Chemicals Ltd.

Showing 5 of 9

FAQs on Aurobindo Pharma Ltd. Business

What does Aurobindo Pharma do?

Aurobindo Pharma is a leading API manufacturing company with a strong presence in various therapeutic domains. Its advanced R&D infrastructure supports the development and delivery of new products, ensuring profitability and growth.

Who are the competitors of Aurobindo Pharma?

Aurobindo Pharma major competitors are Lupin, Mankind Pharma, Alkem Laboratories, Abbott India, Torrent Pharma, Glaxosmithkline Phar, Dr. Reddy's Lab.
Market Cap of Aurobindo Pharma is ₹81,229 Crs.
While the median market cap of its peers are ₹82,327 Crs.

Is Aurobindo Pharma financially stable compared to its peers?

Aurobindo Pharma seems to be less financially stable compared to its peers.
Altman Z score of Aurobindo Pharma is 6.02 and is ranked 8 out of its 8 competitors.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Jun			Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec